Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
Ozempic being a household name, GLP-1 receptor agonists (GLP-1RAs), a class of medications have garnered significant ...
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...
Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...
LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...